Mepolizumab for eosinophilic chronic obstructive pulmonary disease

Mepolizumab for eosinophilic chronic obstructive pulmonary disease

Patients with chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype may benefit from treatment with mepolizumab, a monoclonal antibody directed against interleukin-5.We performed two phase 3, randomized, placebo-controlled, double-blind, parallel-group trials comparing mepolizu...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Pavord, I, Chanez, P, Criner, G, Kerstjens, H, Korn, S, Lugogo, N, Martinot, J, Sagara, H, Albers, F, Bradford, E, Harris, S, Mayer, B, Rubin, D, Yancey, S, Sciurba, F
Materialtyp:	Journal article
Språk:	English
Publicerad:	Massachusetts Medical Society 2017

Liknande verk

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
av: Pavord, I, et al.
Publicerad: (2017)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
av: Bafadhel, M, et al.
Publicerad: (2018)

Mepolizumab for eosinophilic COPD
av: Sciurba, F, et al.
Publicerad: (2018)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function
av: Chapman, K, et al.
Publicerad: (2018)

Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma.
av: Gunsoy, N, et al.
Publicerad: (2017)

Mepolizumab treatment in patients with severe eosinophilic asthma.
av: Ortega, H, et al.
Publicerad: (2014)

Glucocorticoids and mepolizumab in eosinophilic asthma.
av: Bel, E, et al.
Publicerad: (2014)

Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma
av: Shrimanker, R, et al.
Publicerad: (2018)

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
av: Mkorombindo T, et al.
Publicerad: (2019-08-01)

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
av: Pavord, I, et al.
Publicerad: (2012)

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
av: Bel, E, et al.
Publicerad: (2014)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
av: Steven W. Yancey, et al.
Publicerad: (2019-09-01)

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
av: Ortega, H, et al.
Publicerad: (2016)

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
av: Yancey, S, et al.
Publicerad: (2016)

Mepolizumab in refractory eosinophilic asthma.
av: Pavord, I, et al.
Publicerad: (2010)

Mepolizumab, quality of life, and severe eosinophilic asthma.
av: Pavord, I
Publicerad: (2017)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
av: Howell, I, et al.
Publicerad: (2024)

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
av: Prazma CM, et al.
Publicerad: (2021-06-01)

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
av: Ian D. Pavord, et al.
Publicerad: (2022-05-01)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
av: Imran Howell, et al.
Publicerad: (2024-07-01)

Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
av: Terufumi Shimoda, et al.
Publicerad: (2017-07-01)

Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
av: Wechsler, M, et al.
Publicerad: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
av: Moran, AM, et al.
Publicerad: (2020)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
av: Haldar, P, et al.
Publicerad: (2009)

Response to mepolizumab treatment is sustained across 4-weekly dosing periods
av: Ian D. Pavord, et al.
Publicerad: (2020-09-01)

Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies
av: Mi-Kyeong Kim, et al.
Publicerad: (2021-03-01)

Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA
av: Frank C. Albers, et al.
Publicerad: (2019-07-01)

Treatment of eosinophilic myositis with mepolizumab
av: Saadia Waheed, et al.
Publicerad: (2018-01-01)

GLUCOLD, eosinophils and chronic obstructive pulmonary disease
av: Pavord, I
Publicerad: (2018)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
av: Shrimanker, R, et al.
Publicerad: (2017)

Biomarkers for severe eosinophilic asthma.
av: Yancey, S, et al.
Publicerad: (2017)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
av: Menzella F, et al.
Publicerad: (2016-06-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
av: Shrimanker, R, et al.
Publicerad: (2017)

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
av: Moran, A, et al.
Publicerad: (2020)

Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
av: Benjamin Terrier, et al.
Publicerad: (2023-07-01)

Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma
av: Chio Sakai, et al.
Publicerad: (2024-07-01)

Mepolizumab-responsive recurrent eosinophilic eruption without peripheral eosinophilia
av: Nina B. Curkovic, MD, et al.
Publicerad: (2024-11-01)

Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
av: Ravi Ranjan Pradhan, et al.
Publicerad: (2019-01-01)

Effectiveness of mepolizumab for eosinophilic pneumonia following bronchial thermoplasty
av: Ryota Otoshi, et al.
Publicerad: (2020-03-01)

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study
av: Ian Pavord, et al.
Publicerad: (2023-04-01)